somatosensory function Flashcards Preview

Y2 LCRS Neuroscience and Mental Health > somatosensory function > Flashcards

Flashcards in somatosensory function Deck (39)
Loading flashcards...
1
Q

what does nociception provide, and what does the brain perceive this as

A

information about noxious (unpleasant or harmful) stimuli, which the brain perceives as pain

2
Q

difference between nociceptive stimuli and pain

A

nociceptive stimuli can be measured, pain is subjective

3
Q

suscpetibility of pain to contextual influences vs other modalities

A

pain is much more susceptible

4
Q

where are nociception sensory neurone cell bodies

A

in peripheral nervous system (dorsal root ganglion for body or trigeminal ganglia for face)

5
Q

what are the 2 nociception axon types

A

AB, C

6
Q

what are AB nociception axon types used for, and features of transmission

A

mechano- or thermoreceptor; faster, produces sharp pain, leads to avoidance

7
Q

what are C nociception axon types used for, and features of transmission

A

chemoreceptor (eg. bradykinin, histamine); produces dull aching pain, leads to guarding to allow recovery

8
Q

size of nociception receptive fields

A

usually large

9
Q

what is nociception intensity coded by

A

frequency of firing

10
Q

basic central spinothalamic tract pathway: what is information conveyed via

A

VPL (ventral posterolateral) and VPM (ventral posteromedial) nuclei of thalamus

11
Q

basic central spinothalamic tract pathway: where is information conveyed to and why

A

SI and SII cortex, for analysis of localisation and intensity of the noxious stimulus

12
Q

collateral branches to brainstem of spinothalamic tract pathway: where is information conveyed to and why

A

forebrain structures, for perception of pain (afferent pathway)

13
Q

collateral branches to periaqueductal grey of midrain of spinothalamic tract pathway: function

A

inhibit pain (central inhibition pathway)

14
Q

in central spinothalamic pathway, where is somatotropic organisation maintained

A

through entire pathway from dermatomes to cortex

15
Q

where does decussation of the pathway for information coming from the body occur

A

in spinal cord

16
Q

where does decussation of the pathway for information coming from the head occur

A

in brainstem

17
Q

afferent pain pathway (spinothalamic tract/spinal lemniscus) from face

A

face nociceptor-> primary sensory neurone -> through posterior pons down to medulla oblongata-> lateral synapse and decussation as secondary sensory neurone -> pass up through pons and midbrain -> thalamus -> tertiary sensory neurones -> somatosensory cortex

18
Q

afferent pain pathway (spinothalamic tract/spinal lemniscus) from upper limbs

A

upper limb nociceptor -> primary sensory neurone -> posterior cervical cord-> synapse and decussation as secondary sensory neurone -> up spinothalamic tract through medulla oblongata, pons and midbrain -> thalamus -> tertiary sensory neurones -> somatosensory cortex

19
Q

afferent pain pathway (spinothalamic tract/spinal lemniscus) from lower limbs

A

lower limb nociceptor -> primary sensory neurone -> posterior lumbar cord-> synapse and decussation as secondary sensory neurone -> up spinothalamic tract through medulla oblongata, pons and midbrain -> thalamus -> tertiary sensory neurones -> somatosensory cortex

20
Q

where do spinothalamic tract axons send collateral branches to

A

brainstem (reticular formation), thalamus (intralaminar nuclei), hypothalamus and some cortex (e.g. cingulate gyrus, insula)

21
Q

2 effects of axon collateral branches sent from spinothalamic tract

A

triggers increase in awareness, registers unpleasantness of stimulus i.e. pain

22
Q

nociceptive dysfunction: effect of pathway disruption on pain and injury predisposition

A

may reduce pain, but predisposes to increased injury

23
Q

nociceptive dysfunction: 3 changes which may exacerbate pain

A

windup in dorsal horn, thalamic syndrome, phantom pain

24
Q

nociceptor fibres: Ad effect and stimuli (type 1 and type 2)

A

mediate sharp, intense or fast pain; type 1: noxious mechanical; type 2: noxious heat

25
Q

nociceptor fibres: C fibres effect and stimuli

A

mediate dull, aching or second pain; noxious thermal, mechanicl and chemical stimuli

26
Q

spinal cord nociceptive process: first synapse of pain pathway neurotransmitter

A

glutamate

27
Q

sensory component of pain tract

A

lateral spinothalamic tract

28
Q

emotional component of pain tract

A

spinoreticular tract (passes through parabrachial area)

29
Q

functional MRI cerebral signature of pain: cortex

A

SI, SII, insula cortex, anterior cingulate cortex, prefrontal cortex

30
Q

functional MRI cerebral signature of pain: other brain areas

A

amygdala, cerebellum, brainstem

31
Q

nociceptive vs neuropathic pain

A

nociceptive: noxious stimulation of a nociceptor; neuropathic: lesion or disease of somatosensory system; can be mixed e.g. osteoarthritis and lower back pain

32
Q

effect of peripheral sensitisation to pain (“inflammatory soup”)

A

decrease thresholds to peripheral stimuli at site of injury

33
Q

3 effects of central sensitisation to pain (“inflammatory soup”)

A

decrease thresholds to peripheral stimuli at adjacent site of injury, expansion of receptive field, spontaneous pain

34
Q

define hyperalgesia, with reference to primary and secondary; effect on normal pain response sigmoid curve

A

increased pain from stimulus that normally provokes pain (usually thermal or mechanical); primary occurs at area of injury or noxious chemical, secondary occurs around that primary area (shift to left vs normal pain response, at higher stimulus and pain intensity)

35
Q

define allodynia; effect on normal pain response sigmoid curve

A

pain due to stimulus that does not normally invoke pain (shift to left vs normal pain response, at lower stimulus and pain intensity)

36
Q

3 neuropathic pain sensory profiles

A

sensory loss, thermal hyperalgesia, mechanical hyperalgesia

37
Q

descending control and chronic pain: inhibition vs facilitation endogenous drugs

A

inhibitory (protective): noradrenaline; facilitatory (harmful): serotonin

38
Q

state of descending control in chronic pain patients

A

impaired

39
Q

neuromodulation in chronic pain patients: what is done and how does it work

A

non-invasive primary motor cortex stimulation, activating endogenous analgesic systems in brain (periaqueductal grey and anterior cingulate cortex)